Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
05/2003
05/01/2003US20030083347 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
05/01/2003US20030083336 Dopamine D4 receptor ligands; treating psychosis, schizophrenia and affective disorders
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment
05/01/2003US20030083316 Dioxolane nucleosides and nucleoside analogues such as troxacitabine together with chemotherapeutic agents other than doxorubicin such as cytarabine, gemcitabine and idarubicin; synergistic mixture; treating leukemia, cancer
05/01/2003US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease
05/01/2003US20030082769 Human papillomavirus E2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor binding pocket
05/01/2003US20030080323 Novel methine compound, material for organic luminescence element, and organic luminescence element using the same
05/01/2003CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003CA2464981A1 Quinoline compound
05/01/2003CA2464254A1 Inhibitors of post-proline cleaving proteases
05/01/2003CA2463975A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
05/01/2003CA2463101A1 Azole derivatives and pharmaceutical compositions containing them
05/01/2003CA2460680A1 Substituted indazole compounds for the treatment of inflammation
04/2003
04/30/2003CN1414961A Substituted oximes and hydrazones as neurokinin antagonists
04/30/2003CN1414960A Substituted piperidines, medicaments containing these compounds, and methods for production thereof
04/30/2003CN1414953A Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and 5-hydroxytryptamine
04/30/2003CN1414952A Heterocyclic compounds having sulfonic acid
04/30/2003CN1414950A Substituted pyrrole Mannich bases to treating paint and allergic reactions
04/30/2003CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof
04/30/2003CN1413990A Epimino substituted benzene derivative
04/29/2003US6555687 Chloropyrimidine intermediates
04/29/2003US6555663 Prodrugs for selective drug delivery
04/29/2003US6555574 Antiarrhythmic agents
04/29/2003US6555566 Methods and materials for treating and preventing inflammation of mucosal tissue
04/29/2003US6555561 Diaminopyridine-containing thiourea inhibitors of herpes viruses
04/29/2003US6555559 5,6,7-trinor-4,8-inter-m-phenylene PGI2, derivative and drugs containing the same
04/29/2003US6555542 Sulfonamide lactam inhibitors of FXa and method
04/29/2003US6555537 Piperazine derivatives and their use as anti-inflammatory agents
04/24/2003WO2003033493A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ
04/24/2003WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
04/24/2003WO2003033480A1 Lactam derivatives as antagonists for human 11cby receptors
04/24/2003WO2003033476A1 Pyrimidinones as melanin concentrating hormone receptor 1
04/24/2003WO2003033472A1 Quinoline or quinazoline derivatives inhibiting auto- phosphorylation of fibroblast growth factor receptors
04/24/2003WO2003032997A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
04/24/2003WO2003032984A1 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
04/24/2003WO2003032982A1 Bis-heteroaryl alkanes as therapeutic agents
04/24/2003WO2003032981A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
04/24/2003WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032912A2 Treatment of cns disorders using cns target modulators
04/24/2003WO2003032910A2 Carbinols for the treatment of neuropathic dysfunction
04/24/2003WO2003032903A2 Trisubstituted triazines compounds with antitubulin activity
04/24/2003WO2003000679A3 Herbicidal substituted pyridines, method for producing the same and their use as herbicidal agents and plant growth regulators
04/24/2003WO2002068406A3 Substituted amine derivatives and their use for the treatment of angiogenesis
04/24/2003WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/24/2003WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003US20030078427 Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
04/24/2003US20030078420 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
04/24/2003US20030078418 Useful potentiators of beta -lactam antibiotics; therapy
04/24/2003US20030078347 Triazine compounds, polymers comprising triazine structural units, and method
04/24/2003US20030078288 Indole derivatives
04/24/2003US20030078282 For therapy of allergic dermatitis and atopy in animals and humans
04/24/2003US20030078276 Matrix metalloproteinase inhibitors
04/24/2003US20030078275 For therapy of cancer, diabetes and Alzheimer's disease
04/24/2003US20030078271 Pyrimidine and indolone derivatives
04/24/2003US20030078265 Inhibitors of nitric oxide synthase (nos)
04/24/2003US20030078261 Prostaglandin agonists
04/24/2003US20030078260 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
04/24/2003US20030078258 Adrenergic blocking agents
04/24/2003US20030078253 Matrix metalloprotease inhibitors
04/24/2003US20030078166 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003CA2463579A1 Treatment of cns disorders using cns target modulators
04/24/2003CA2463518A1 Carbinols for the treatment of neuropathic dysfunction
04/24/2003CA2463509A1 Lactam derivatives as antagonists for human 11cby receptors
04/24/2003CA2463508A1 Pyrimidinones as melanin concentrating hormone receptor 1
04/24/2003CA2463469A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
04/23/2003EP1304324A1 Serotonin reuptake inhibitors
04/23/2003EP1304101A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications
04/23/2003EP1303641A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
04/23/2003EP1303509A1 Beta3 adrenergic agonists
04/23/2003EP1303508A1 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents
04/23/2003EP1303506A1 6-heteroarylphenanthridines
04/23/2003EP1303505A1 Phenyl-substituted 5,6-dihydropyrone derivatives for use as pesticides and herbicides
04/23/2003EP1303499A1 Tetrazole derivatives
04/23/2003EP1303498A1 Substituted 2-amino-1,3,5-triazines, and the use thereof as herbicides and plant growth regulators
04/23/2003EP1303497A1 Substituted amidoalkyl-uracils as parp inhibitors
04/23/2003EP1303496A1 Pyrimidine derivatives
04/23/2003EP1303495A1 Substituted 5-alkynyl pyrimidines having neurotrophic activity
04/23/2003EP1303488A1 Piperidine compounds for use as ccr-3 inhibitors
04/23/2003EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors
04/23/2003EP1303482A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
04/23/2003EP1303281A1 Methods of treatment
04/23/2003EP1153023B1 Process for the production of paroxetine
04/23/2003EP1133483B1 Il-5 inhibiting 6-azauracil derivatives
04/23/2003EP1077975B1 Water soluble azoles as broad-spectrum antifungals
04/23/2003EP1027359B1 Monocyclic l-nucleosides, analogs and uses thereof
04/23/2003EP0915846B1 2- and 2,5-substituted phenylketoenols
04/23/2003EP0854723B1 Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies as antiinflammatory agents
04/23/2003EP0836615B1 New thrombin inhibitors, their preparation and use
04/23/2003CN1413207A 5-membered ring heterocyclic compounds with nitrogen
04/23/2003CN1413206A Non peptide tachykinin receptor antagonists
04/23/2003CN1413205A 2-(1H-indol-3-yl)-2-oxo-acetamides with antitumor activity
04/23/2003CN1413198A Methods and compositions utilizing quianzolinones
04/23/2003CN1413193A Nitrile derivatives as cathepsin K inhibitors
04/23/2003CN1413192A Substituted indole mannich bases
04/23/2003CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
04/23/2003CN1411809A Usage and composition of pyridine onium derivative for curing application
04/23/2003CN1411800A Cosmetic composition and method
04/23/2003CN1106387C PDEIV inhibiting 2-cyanoiminoimidazole derivatives
1 ... 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 ... 694